Pharma Green Holding
Pharma Green Holding is a company that aims to create a unified and advanced pharmacy network that delivers healthcare solutions.
Pharma Green Holding is a company that aims to create a unified and advanced pharmacy network that delivers healthcare solutions.
Pharma Green Holding has raised $11.6M across 1 round. Its most recent round was a Series Unknown of $11.6M in Jun 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Pharma Green Holding is featured in
Similar companies
Niino is a digital healthcare logistics platform provide easy, rapid, and transparent access to non-urgent medical rides, transforming a historically fragmented and analog sector into an automated, digital-first experience.
Salute360 is a digital health company committed to transforming the way patients and healthcare professionals connect and interact. We designed and developed an integrated platform that simplifies access to reliable healthcare information and digital services, compliant to EU Health Regulation and HIPAA. Our mission is to make healthcare more accessible, secure, and patient-centered through smart digital solutions. Salute360 empowers healthcare professionals and organizations to deliver more efficient, collaborative, and personalized care - whether in prevention, treatment, or ongoing health management. We support pharmacies, clinics, life science companies, insurance providers, and welfare programs in enhancing their services and creating innovative digital health strategies. At the heart of our work is a connected ecosystem that fosters collaboration and puts the patient at the center of a more intuitive and inclusive healthcare experience.
Rosso is a startup in Italy focused on addressing the blood shortage crisis by connecting various institutions in the blood supply chain. Their main aim is to reduce wait times for patients by increasing the number of donors, particularly among young people. They use social media campaigns and a booking platform to encourage young donors to book donations at nearby centers and provide them with access to hematologists for any concerns. They also work with companies to engage employees in health prevention and blood donation through welfare programs and sustainability memberships. In addition, they offer hospital management software to optimize blood stock management and predict future needs using AI technology.
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemICare’s mission is the improvement of the quality of life of patients affected by Tubular Aggregate Myopathy, York Platelet Syndrome and Stormorken Syndrome by the development of a therapy that restores the abnormal intracellular calcium level, a common feature of these three rare diseases.
Antonio D'Angelo and Andrea Cazzulani discovered that a highly effective medication was struggling to become widely accepted as the standard treatment due to issues such as high cost and inconvenient devices. Despite clinical evidence showing its superiority, incisional negative pressure therapy was being surpassed by absorbent wound dressings. In response, Antonio and Andrea teamed up to establish Medicud in 2020, creating a innovative single-use i-NPWT device that is user-friendly and environmentally friendly. Their goal with Medicud is to become a leading provider of sustainable medical solutions on a global scale.
Approxima is a new MedTech startup in the early stages of developing a method for replacing the tricuspid valve using a percutaneous approach. The company is showing the safety, effectiveness, and viability of this method through preclinical trials in the feasibility phase.
Restorative Neurotechnologies is a pioneer in non-invasive neuromodulation for the rehabilitation of cognitive function. The company has completed multiple clinical studies demonstrating its digital therapy, MindLenses Professional, delivers superior clinical outcomes in domains such as attention, memory, language and executive functions compared to alternatives, in a faster therapeutic cycle. MindLenses Professional is CE-marked and a Class IIa Medical Device under European Union Medical Device Regulation (MDR) 2017/745 for post-stroke cognitive rehabilitation. The company’s technology is based on pioneering research on prismatic adaptation by founders Professor Massimiliano Oliveri at the University of Palermo, Italy, and at Harvard. Restorative Neurotechnologies' Quality Management System is certified according to ISO 13485:2016.
Dentistry nutraceuticals
We apply IT to Bionics in order to Turn disabilities into New Possibilities
Soundsafe Care is a medical startup company that disrupts traditional surgical practices by combining ultrasound and robotics. This innovative approach allows for precise, non-invasive surgery. The use of ultrasound therapy eliminates the need for incisions and radiation, while robotics enhances precision and safety. Soundsafe Care has the potential to revolutionize tumor treatment for humans and animals. The company's team has extensive experience in the field, with numerous research projects, scientific papers, and innovation awards. Soundsafe Care is supported by Scuola Superiore Sant'Anna, Pariter Partners, Imec, RoboIT, Toscana Next, and CDP Venture Capital SGR.
ADOR develops, manufactures and markets unique in-vitro diagnostic solutions, which is specially designed for small to mid-sized laboratories, doctor offices, point of care, near-bed testing, specific hospital settings, (rural) labs and mobile care units. ADOR is proud to introduce a new and exciting Molecular Diagnostics platform that will revolutionize the way small-medium laboratories test for infectious diseases.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.